B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Cediranib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cediranib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

vandetanib
70 shared targets
brivanib
36 shared targets
osi
38 shared targets
canertinib
57 shared targets
raf
42 shared targets
rebastinib
52 shared targets
saracatinib
36 shared targets
erlotinib
51 shared targets
defosbarasertib
40 shared targets
pazopanib
51 shared targets
Loading evidence profile...

This evidence profile for Cediranib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.